Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A highly accurate, low cost test for BRCA1 mutations.

N J van Orsouw1, R K Dhanda, Y Elhaji

  • 1Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78229, USA. nvorsouw@saci.org

Journal of Medical Genetics
|October 21, 1999
PubMed
Summary

Researchers developed an inexpensive screening system for hereditary breast and ovarian cancer (HBOC) syndrome mutations. This method efficiently detects BRCA1 mutations, potentially lowering diagnostic costs and improving genetic testing accessibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Palliative and supportive care underutilization for patients with locally advanced pancreatic cancer: review of the NCDB.

ESMO gastrointestinal oncology·2026
Same author

Positioning EGFR re-treatment in modern metastatic colorectal cancer: insights from PARERE.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.

ESMO open·2025
Same author

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022.

ESMO open·2023
Same author

An epistatic interaction between pre-natal smoke exposure and socioeconomic status has a significant impact on bronchodilator drug response in African American youth with asthma.

BioData mining·2020

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Hereditary breast and ovarian cancer (HBOC) syndrome is linked to frequent BRCA1 mutations.
  • BRCA1 testing is limited by insurance fears, uncertain clinical value, and high costs.
  • A need exists for inexpensive and sensitive BRCA1 mutation screening methods.

Purpose of the Study:

  • To develop and evaluate an inexpensive and sensitive screening system for BRCA1 mutations.
  • To assess the efficiency of a novel multiplex PCR and 2D electrophoresis method.
  • To reduce the cost and improve accessibility of BRCA1 mutation detection.

Main Methods:

  • Developed a gene mutational scanning system using multiplex PCR amplification and 2D electrophoresis.
  • Evaluated the system on 60 high-risk women's samples, including 14 with known BRCA1 mutations.

Related Experiment Videos

  • Confirmed detected mutations and polymorphisms using nucleotide sequencing.
  • Main Results:

    • Successfully identified all 14 known BRCA1 mutations and discovered five additional mutations.
    • Detected 15 different polymorphic variants, confirming the system's comprehensive scanning capability.
    • Estimated screening cost at ~$70 per sample, reducible to ~$10 with automation.

    Conclusions:

    • The developed multiplex PCR and 2D electrophoresis system is an efficient and cost-effective method for screening BRCA1 mutations.
    • This technology can overcome current limitations in BRCA1 testing, enhancing clinical and research applications.
    • Facilitates genotype-phenotype data collection for improved diagnostic test evaluation.